4

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
May 24, 2018
Document Date
May 22, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
KemPharm
Issuer
KEMPHARM INC
Filer
Plooster Matthew R